Status: Recruiting
Pancreatic Cancer Detection Consortium
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: City of Hope Medical CenterUpdated: Dec 19, 2025Locations: 11
Eligibility criteria
Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM cla... [+2]
Lack of written informed consent.